fingolimod hydrochloride has been researched along with Diabetes Mellitus, Type 2 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 5 (71.43) | 2.80 |
| Authors | Studies |
|---|---|
| An, A; Gong, K; Li, Q; Lu, X; Ma, ZA; Song, W; Wang, X; Wang, YJ; Xiao, YF; Xu, L; Yu, G; Zang, M | 1 |
| Fernandes, V; Khatri, DK; Khot, M; Preeti, K; Singh, SB; Sood, A | 1 |
| Fernandes, V; Khatri, DK; Preeti, K; Singh, SB; Sood, A | 1 |
| Blecharz-Klin, K; Mirowska-Guzel, D; Piechal, A; Pyrzanowska, J; Strosznajder, RP; Wencel, PL | 1 |
| Ishii, Y; Katsuda, Y; Kobayashi, K; Miyajima, K; Ohta, T; Sasase, T; Yamada, T | 1 |
| Choi, J; Chon, J; In, J; Joo, J; Kim, D; Lee, H; Moon, H; Park, J | 1 |
| Hupfeld, CJ; Kendall, MR | 1 |
1 trial(s) available for fingolimod hydrochloride and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Immunomodulator FTY720 improves glucose homeostasis and diabetic complications by rejuvenation of β-cell function in nonhuman primate model of diabetes.
Topics: Animals; Diabetes Complications; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Glucose; Glycated Hemoglobin; Homeostasis; Immunologic Factors; Insulin; Male; Primates; Rejuvenation | 2022 |
6 other study(ies) available for fingolimod hydrochloride and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Fingolimod Alleviates Cognitive Deficit in Type 2 Diabetes by Promoting Microglial M2 Polarization via the pSTAT3-jmjd3 Axis.
Topics: Animals; Cell Polarity; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Mice; Microglia; Neuroinflammatory Diseases; Signal Transduction | 2023 |
Sphingosine 1 phosphate lyase inhibition rescues cognition in diabetic mice by promoting anti-inflammatory microglia.
Topics: Animals; Apoptosis Regulatory Proteins; Cognition; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Mice; Microglia; Neuroinflammatory Diseases; Phosphates; Phosphoric Monoester Hydrolases; Sphingosine; Tumor Suppressor Protein p53 | 2023 |
Fingolimod Modulates the Gene Expression of Proteins Engaged in Inflammation and Amyloid-Beta Metabolism and Improves Exploratory and Anxiety-Like Behavior in Obese Mice.
Topics: Amyloid Precursor Protein Secretases; Animals; Anxiety; Aspartic Acid Endopeptidases; bcl-2-Associated X Protein; Cytokines; Diabetes Mellitus, Type 2; Fingolimod Hydrochloride; Gene Expression; Inflammation; Mice; Mice, Obese; Obesity; Receptors, Lysosphingolipid; RNA, Messenger | 2023 |
The sphingosine-1-phosphate receptor modulator, FTY720, prevents the incidence of diabetes in Spontaneously Diabetic Torii rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Fingolimod Hydrochloride; Incidence; Sphingosine-1-Phosphate Receptors | 2021 |
FTY720 preserved islet β-cell mass by inhibiting apoptosis and increasing survival of β-cells in db/db mice.
Topics: Animals; Apoptosis; Blood Glucose; Body Weight; Cell Survival; Diabetes Mellitus, Type 2; Female; Fingolimod Hydrochloride; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Mice; Propylene Glycols; Sphingosine | 2013 |
FTY720, a sphingosine-1-phosphate receptor modulator, reverses high-fat diet-induced weight gain, insulin resistance and adipose tissue inflammation in C57BL/6 mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 2; Fasting; Fingolimod Hydrochloride; Glucose Tolerance Test; Immunosuppressive Agents; Insulin; Insulin Resistance; Lymphopenia; Male; Mice; Mice, Inbred C57BL; Panniculitis; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; Weight Gain | 2008 |